autolymphocyte therapy

autolymphocyte therapy

A form of immunotherapy for treating metastatic renal carcinoma, in which a patient’s leukocytes are removed, stimulated by monoclonal antibodies, causing them to produce and secrete cytokines. The cytokine supernatant is then removed and readministered to the patient. Despite early reports of success, this therapy has been discontinued.

autolymphocyte therapy

Experimental oncology A form of immunotherapy for treating metastatic renal carcinoma, in which a Pt's WBCs are removed, stimulated by monoclonal antibodies, which causes the WBCs to produce and secrete cytokines; the cytokine supernatant is then removed and readministered with an aliquot of the Pt's own WBCs. Cf Immunoaugmentive therapy.
Mentioned in ?
References in periodicals archive ?
Specifically, they aim to assess the safety and efficacy of combination therapy of gemcitabine and activated autolymphocyte therapy in patients with respectable pancreatic cancer.
Specifically, the two partners have begun animal experiments to assess the efficacy of activated autolymphocyte therapy and dendritic cell therapy in the treatment of various cancers.